These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10845268)

  • 21. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
    Griffiths UK; Hutton G; Das Dores Pascoal E
    Health Policy Plan; 2005 Jan; 20(1):50-9. PubMed ID: 15689430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Costs of guideline-based treatment of hepatitis B patients in Germany].
    Stahmeyer JT; Becker H; Heidelberger S; Wiebner B; Deterding K; Cornberg M; Manns MP; Krauth C; Wedemeyer H
    Z Gastroenterol; 2012 Aug; 50(8):745-52. PubMed ID: 22895902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B vaccine: a pharmacoeconomic evaluation of its use in the prevention of hepatitis B virus infection.
    Holliday SM; Faulds D
    Pharmacoeconomics; 1994 Feb; 5(2):141-71. PubMed ID: 10146907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Survey of economic burden of hepatitis B-related diseases in 12 areas in China].
    Ma QS; Liang S; Xiao HW; Zhang SX; Zhuang GH; Zou YH; Tan HZ; Liu JC; Zhang YH; Xu AQ; Zhang L; Feng XX; Hu DS; Wang FZ; Cui FQ; Liang XF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):868-876. PubMed ID: 28738457
    [No Abstract]   [Full Text] [Related]  

  • 25. An economic evaluation of universal infant vaccination strategies against hepatitis B in Thailand: an analytic decision approach to cost-effectiveness.
    Vimolket T; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):693-9. PubMed ID: 16124440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic evaluations of hepatitis B vaccination for developing countries.
    Tu HA; Woerdenbag HJ; Kane S; Riewpaiboon A; van Hulst M; Postma MJ
    Expert Rev Vaccines; 2009 Jul; 8(7):907-20. PubMed ID: 19538116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer's data sources.
    Ruof J; Hülsemann JL; Mittendorf T; Handelmann S; von der Schulenburg JM; Zeidler H; Merkesdal S
    Ann Rheum Dis; 2003 Jun; 62(6):544-9. PubMed ID: 12759292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [HBV-infections in Germany - health care costs in a real-life-setting].
    Stahmeyer JT; Becker H; Orlemann AL; Krauth C; Manns MP; Wedemeyer H
    Z Gastroenterol; 2017 Nov; 55(11):1103-1112. PubMed ID: 29141265
    [No Abstract]   [Full Text] [Related]  

  • 29. Cost-effectiveness of the controlled temperature chain for the hepatitis B virus birth dose vaccine in various global settings: a modelling study.
    Scott N; Palmer A; Morgan C; Lesi O; Spearman CW; Sonderup M; Hellard M
    Lancet Glob Health; 2018 Jun; 6(6):e659-e667. PubMed ID: 29773122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cost of integrating hepatitis B virus vaccine into national immunization programmes: a case study from Addis Ababa.
    Edmunds W; Dejene A; Mekonnen Y; Haile M; Alemnu W; Nokes D
    Health Policy Plan; 2000 Dec; 15(4):408-16. PubMed ID: 11124244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An economic analysis of premarriage prevention of hepatitis B transmission in Iran.
    Adibi P; Rezailashkajani M; Roshandel D; Behrouz N; Ansari S; Somi MH; Shahraz S; Zali MR
    BMC Infect Dis; 2004 Sep; 4():31. PubMed ID: 15347430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic evaluation of a 2-dose hepatitis B vaccination regimen for adolescents.
    Levaux HP; Schonfeld WH; Pellissier JM; Cassidy WM; Sheriff SK; Fitzsimon C
    Pediatrics; 2001 Aug; 108(2):317-25. PubMed ID: 11483794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B virus vaccine. Cost-benefit analysis of its use in a children's hospital.
    Hicks RA; Cullen JW; Jackson MA; Burry VF
    Clin Pediatr (Phila); 1989 Aug; 28(8):359-65. PubMed ID: 2527103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B virus vaccination of blood donors--what costs may be expected?
    Ringwald J; Mertz I; Zimmermann R; Weisbach V; Strasser E; Achenbach S; Seyboth S; Richter E; Eckstein R
    Transfus Med; 2005 Apr; 15(2):83-92. PubMed ID: 15859973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-benefit analysis of the Polish hepatitis B prevention programme.
    Wiewióra-Pilecka D
    Vaccine; 2000 Feb; 18 Suppl 1():S52-4. PubMed ID: 10683548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health and economic impact of posttransfusion hepatitis B and cost-effectiveness analysis of expanded HBV testing protocols of blood donors: a study focused on the European Union.
    Pereira A
    Transfusion; 2003 Feb; 43(2):192-201. PubMed ID: 12559015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Decision tree and cost-benefit analysis on strategies related to preventing maternal-infantile transmission of hepatitis B virus infection].
    Shi G; Zhang SX
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Mar; 34(3):273-8. PubMed ID: 23759236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of hepatitis B vaccination of prison inmates.
    Pisu M; Meltzer MI; Lyerla R
    Vaccine; 2002 Dec; 21(3-4):312-21. PubMed ID: 12450707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cost of illness in Parkinson disease. A retrospective 3-month analysis of direct costs].
    Dodel RC; Singer M; Köhne-Volland R; Selzer R; Scholz W; Rathay B; Oertel WH
    Nervenarzt; 1997 Dec; 68(12):978-84. PubMed ID: 9465341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cost effectiveness of hepatitis immunization for US college students.
    Jacobs RJ; Saab S; Meyerhoff AS
    J Am Coll Health; 2003 May; 51(6):227-36. PubMed ID: 14510025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.